|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.97 USD | -1.00% |
|
-0.67% | +11.24% |
| Jun. 07 | NeurAxis Submits Application to FDA to Expand IB-Stim Label | MT |
| May. 22 | Earnings Flash (NRXS) NEURAXIS Posts Q1 Revenue $646,635 | MT |
NeurAxis, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 0.646635 million compared to USD 0.80511 million a year ago. Net loss was USD 2.12 million compared to USD 2.17 million a year ago.
Basic loss per share from continuing operations was USD 0.32 compared to USD 1.18 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +11.24% | 19.74M | |
| +75.69% | 12.57B | |
| -25.35% | 7.28B | |
| +15.77% | 7.2B | |
| +14.52% | 5.47B | |
| -18.50% | 4.73B | |
| +14.91% | 4.09B | |
| -23.67% | 3.78B | |
| +42.93% | 2.3B | |
| -0.37% | 2.03B |
NEURAXIS, INC. 
